Comparison of fingolimod and teriflunomide on the basis of relapse, magnetic resonance imaging and cognition following the switch from injectables in patients with stable multiple sclerosis | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.

January 2019

OBJECTIVE: Oral immunotherapies have become a standard treatment in relapsing-remitting multiple scl...

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

August 2019

International audienceObjective: In this study, we compared the effectiveness of teriflunomide (TRF)...

Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis

TERZİ, MURAT
BOZ, CAVİT
Ozer, Bilge
Turkoglu, Recai
KARABUDAK, RANA
EFENDİ, HÜSNÜ
AKÇALI, AYLİN
Altintas, Ayse
Sevim, Serhan
Soysal, Aysun
Akman, Gulsen
Kurne, Asli
ÖZAKBAŞ, SERKAN
Koseoglu, Mesrure
Kale, Nilufer
GozubatikCelik, Gokcen
TURAN, ÖMER FARUK
Altunrende, Burcu
Demirkiran, Meltem
Karahan, Serap Zengin
EKMEKCİ, ÖZGÜL
Balci, Belgin Petek
YÜCEYAR, AYŞE NUR

November 2019

Background: Fingolimod and teriflunomide are commonly used in the treatment of relapsing-remitting m...

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

April 2019

Objective Oral immunotherapies have become a standard treatment in relapsing-remitting multiple scle...

Comparative analysis of fingolimod versus teriflunomide in relapsing–remitting multiple sclerosis

Boz C.
Terzi M.
Özer B.
Turkoglu R.
Karabudak R.
Efendi H.
Soysal A.

January 2019

PubMedID: 31473488Background: Fingolimod and teriflunomide are commonly used in the treatment of rel...

Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis

Boz, C.
Ozakbas, S.
Terzi, M.
Turkoglu, R.
Akman, G.
Efendi, H.
Akcali, A.
Tuncer, A.
Yuceyar, N.
Turan, O. F.
Soysal, A.
Koseoglu, M.
Balci, B. P.
Sevim, S.
Altintas, A.
Cilingir, V.
Demirkiran, M.
Kizilay, F.
Altunrende, B.

January 2017

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Com...

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.

January 2019

OBJECTIVE: Oral immunotherapies have become a standard treatment in relapsing-remitting multiple scl...

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

August 2019

International audienceObjective: In this study, we compared the effectiveness of teriflunomide (TRF)...

Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis

TERZİ, MURAT
BOZ, CAVİT
Ozer, Bilge
Turkoglu, Recai
KARABUDAK, RANA
EFENDİ, HÜSNÜ
AKÇALI, AYLİN
Altintas, Ayse
Sevim, Serhan
Soysal, Aysun
Akman, Gulsen
Kurne, Asli
ÖZAKBAŞ, SERKAN
Koseoglu, Mesrure
Kale, Nilufer
GozubatikCelik, Gokcen
TURAN, ÖMER FARUK
Altunrende, Burcu
Demirkiran, Meltem
Karahan, Serap Zengin
EKMEKCİ, ÖZGÜL
Balci, Belgin Petek
YÜCEYAR, AYŞE NUR

November 2019

Background: Fingolimod and teriflunomide are commonly used in the treatment of relapsing-remitting m...

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

April 2019

Objective Oral immunotherapies have become a standard treatment in relapsing-remitting multiple scle...

Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis

Boz, C.
Ozakbas, S.
Terzi, M.
Turkoglu, R.
Akman, G.
Efendi, H.
Akcali, A.
Tuncer, A.
Yuceyar, N.
Turan, O. F.
Soysal, A.
Koseoglu, M.
Balci, B. P.
Sevim, S.
Altintas, A.
Cilingir, V.
Demirkiran, M.
Kizilay, F.
Altunrende, B.

January 2017

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Com...

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.

January 2019

OBJECTIVE: Oral immunotherapies have become a standard treatment in relapsing-remitting multiple scl...

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

August 2019

International audienceObjective: In this study, we compared the effectiveness of teriflunomide (TRF)...